Contrast Ultrasound Assessment of Perfusion Changes After Peripheral Artery Revascularization

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study represents an important step to validate the use of contrast-enhanced ultrasound (CEU) as a clinical research tool that can be used as a biologic readout of new therapies for Peripheral Artery Disease (PAD), and as a clinically-reasonable method for assessing impact of revascularization. The primary aim is to establish that CEU limb perfusion imaging can be used to accurately assess therapeutic improvements in tissue perfusion that are linked to symptom improvement.
Epistemonikos ID: 3cbc45c0a465d0f3bf05bf0bf9318637759a49c2
First added on: May 22, 2024